Mammographic surveillance in breast cancer patients aged 50 years or older
STUDY RECRUITMENT COMPLETED!
Many thanks to all Participants, Research Teams and Principal Investigators for your hard work and support helping us to achieve this amasing milestone.
Mammo-50 is a multi-centre, randomised, controlled, phase III trial of annual mammography versus 2 yearly for conservation surgery patients or 3 yearly for mastectomy patients.
Also an observational cohort study was offered to those patients for whom the specialist or patient opts for standard mammography per local practice or immediate discharge to the screening programme or stopping mammography altogether.
An integrated feasibility study assessed the willingness for centres and patients to participate in the trial and explore reasons for non-randomisation of the cohort patients.
All patients are being asked to complete the Mammo-50 patient questionnaire booklet and followed up in terms of recurrence and survival in accordance with the protocol.
Mammo-50 is funded by the NIHR Health Technology Assessment Programme
The study is sponsored by
The patient advocacy group Independent Cancer Patients' Voice has contributed to the study design, development of the patient information sheet and is represented on the Trial Management Group.
Please direct all general enquiries to:
mammo-50 at warwick dot ac dot uk
Maria Ramirez, Clinical Trial Manager
T: 02476 575 856
E: maria dot ramirez at warwick dot ac dot uk
Caroline Jevons, Recruitment Facilitator
T: 02476 150 990
E: c dot jevons at warwick dot ac dot uk
Asha Bhandari, Trial Administrator
T: 02476 151 072
E: asha dot bhandari at warwick dot ac dot uk
John Lindley, Data Entry Clerk
T: 02476 573 368
E: j dot lindley dot 1 at warwick dot ac dot uk